- Home
- ORKA vs ADV Comparison
ORKA vs ADV Comparison
Compare ORKA & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORKA | ADV |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 293.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORKA | ADV |
|---|---|---|
| Price | $31.80 | $0.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $48.20 | $2.00 |
| AVG Volume (30 Days) | 647.4K | ★ 1.1M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,502,796,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.49 | $0.80 |
| 52 Week High | $32.64 | $3.07 |
Technical Indicators
Market Signals| Indicator | ORKA | ADV |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 41.71 |
| Support Level | $27.84 | $0.80 |
| Resistance Level | $32.64 | $0.94 |
| Average True Range (ATR) | 1.93 | 0.07 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 80.73 | 44.02 |
Price Performance
Historical ComparisonAbout ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.